ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,921Medicare Part D Prescriptions Filled, Including Refills

Rank: 78 out of 761

$544K Total Retail Price of All Prescriptions

Rank: 101 out of 761

444 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

18% of this provider’s 444 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

23% of this provider’s 444 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 6,937 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
HYDROCODONE-ACETAMINOPHEN 536 296 S3 1 5
LISINOPRIL 453 323 2 1
LEVOTHYROXINE SODIUM 355 254 3 3
WARFARIN SODIUM 340 288 4 9
SIMVASTATIN 328 229 5 2
OXYCODONE HCL 283 85 S2 6 24
OMEPRAZOLE 266 170 7 4
ATORVASTATIN CALCIUM 222 150 8 12
AMLODIPINE BESYLATE 220 177 9 6
FUROSEMIDE 219 179 10 7
ATENOLOL 188 110 11 8
HYDROCHLOROTHIAZIDE 186 150 12 11
METOPROLOL TARTRATE 178 152 13 14
ZOLPIDEM TARTRATE 166 97 14 22
CITALOPRAM HBR 162 86 15 19
GABAPENTIN 159 75 16 15
METHADONE HCL 152 29 S2 17 75
VENTOLIN HFA 126 95 18 111
METFORMIN HCL 125 98 19 10
IBUPROFEN 121 33 20 103
CARVEDILOL 120 94 21 26
SERTRALINE HCL 120 97 21 25
GLIPIZIDE 117 99 23 39
ALLOPURINOL 115 85 24 28
POTASSIUM CHLORIDE 112 79 25 18
AMITRIPTYLINE HCL 108 60 R 26 54
FENTANYL 99 66 S2 27 57
PREDNISONE 91 67 28 30
SPIRIVA 90 55 29 56
TAMSULOSIN HCL 90 87 29 27
HYDROXYZINE HCL 89 17 R 31 229
MORPHINE SULFATE ER 87 22 S2 32 38
LOSARTAN POTASSIUM 87 64 32 13
CLONIDINE HCL 86 50 34 69
MIRTAZAPINE 83 58 35 50
PROMETHAZINE HCL 83 31 R 35 104
OXYCODONE-ACETAMINOPHEN 83 43 S2 35 49
POLYETHYLENE GLYCOL 3350 79 53 38 62
PROPRANOLOL HCL 79 72 38 100
LOVASTATIN 74 59 40 17
IMIPRAMINE HCL 72 25 R 41 292
METOPROLOL SUCCINATE 71 26 42 16
CYCLOBENZAPRINE HCL 64 18 R 43 51
PROAIR HFA 63 14 44 32
CYMBALTA 62 52 45 53
DIGOXIN 61 61 46 43
OXYCONTIN 61 34 S2 46 114
BETAMETHASONE VALERATE 60 44 48 316
COMBIVENT 60 47 48 110
ENALAPRIL MALEATE 59 58 50 71
TRAZODONE HCL 57 24 51 23
PRAVASTATIN SODIUM 56 49 52 20
NAPROXEN 54 16 53 105
PAROXETINE HCL 53 28 54 47
VENLAFAXINE HCL ER 51 38 55 76
FLUOXETINE HCL 50 46 56 31
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 21, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.